ArticleCancer2021

Outcomes in patients with newly diagnosed TP53-mutated acute myeloid leukemia with or without venetoclax-based therapy.

Sangeetha Venugopal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.